Shaping the future of
metabolic disease
outcomes.
Powering the future of purpose-built proteins.
Improving the lives of millions living with obesity and related health conditions is driving our vision for a better future. With integrated machine learning and data-driven patient insights, we’re building a pipeline of enhanced biologics designed to combat metabolic disease.
Obesity is a complex disease.
Obesity is a disease layered with many contributing determinants such as environmental, sociocultural, genetic, biological and behavioral factors. Many individuals struggle with weight loss and regain, leading to increased health risks, frustration and stigma.
Furthermore, obesity acts as a central risk factor that exacerbates the onset and severity of metabolic, cardiovascular, and musculoskeletal comorbidities.
Delivering broad metabolic health.
Nearly every major organ system is affected by obesity-related comorbidities. Obesity is associated with more than 200 medical complications and can reduce productivity while increasing healthcare costs.
Tomorrow’s treatment will be focused on addressing the needs of specific patient segments through the design and development of customized medicines for obesity and its complications.
“Data-driven patient
insights coupled with
AI-driven protein design
are unlocking the next
generation of obesity
treatment.”
